All Episodes

June 17, 2023 69 mins

Guest Name: Dr. Erica Zelfand
Guest Bio: Dr. Erica Zelfand specializes in integrative mental health. In addition to treating patients of all ages in her medical practice, she’s a psychedelic therapist and ketamine provider. Dr. Z is a lead educator in the country’s first licensed psilocybin facilitator school (InnerTrek.org), mentor, and an acclaimed international speaker.

Her work focuses on bridging the gaps between mind, body, and spirit, and unifying conventional and alternative modalities. She is the author of a literature review on the potential of ascorbic acid to treat opioid withdrawal (PMID 33132774) and has written many articles on a variety of health topics. Dr. Zelfand is also the CEO of Right to Heal, a nonprofit committed to empowering individuals to reclaim their health..

Links to guest’s website and/or social media:
RightToHeal.com
www.linkedin.com/in/drzelfand/
Instagram.com/DrZelfand
facebook.com/DrZelfand

Episode Summary:
In this captivating episode of PsychedelicIQ, host Gv Freeman delves deep into the world of psychedelic experiences with the Dr. Erica Zelfand. Contrary to popular belief, Dr. Zelfand discusses the reality of “bad trips” in psychedelic journeys. Drawing from her expertise in integrative and functional medicine, she sheds light on the psychological and physiological factors that can contribute to challenging experiences while under the influence of psychedelics.

Listeners are taken on a journey through the complexities of the mind as Dr. Zelfand explores the various reasons why individuals may encounter difficult trips, ranging from unresolved trauma to underlying mental health conditions. Through her compassionate approach, she emphasizes the importance of proper preparation, set, and setting to navigate these potentially turbulent waters safely.

Moreover, Dr. Zelfand provides invaluable insights into harm reduction strategies and the significance of integration after psychedelic experiences. By fostering a deeper understanding of the intricacies involved in psychedelic trips, this episode offers listeners a newfound appreciation for the transformative potential of these substances while highlighting the importance of responsible usage and informed decision-making.

Tune in to this enlightening conversation to gain valuable insights into the transformative potential of psychedelics while prioritizing mental well-being and safety.

Show Notes:
[05:24] Introduction to Dr. Erica Zelfand
[00:00] Guest’s expertise in integrative and functional medicine.
[14:36 ] Insight about the ‘Let’s Talk About Bad Trips: Separating Difficult from Traumatic’
[16:19] Factors contributing to challenging psychedelic experiences
[24:18] Exploring underlying mental health conditions and their influence on trip outcomes
[28:17] Dr. Erica Zelfand take on deep spiritual space
[35:43] Myth about ‘Bad Trips’
[39:12] Understanding unresolved trauma and its impact on psychedelic journeys

Mark as Played

Advertise With Us

Popular Podcasts

Dateline NBC
Let's Be Clear with Shannen Doherty

Let's Be Clear with Shannen Doherty

Let’s Be Clear… a new podcast from Shannen Doherty. The actress will open up like never before in a live memoir. She will cover everything from her TV and film credits, to her Stage IV cancer battle, friendships, divorces and more. She will share her own personal stories, how she manages the lows all while celebrating the highs, and her hopes and dreams for the future. As Shannen says, it doesn’t matter how many times you fall, it’s about how you get back up. So, LET’S BE CLEAR… this is the truth and nothing but. Join Shannen Doherty each week. Let’s Be Clear, an iHeartRadio podcast.

The Dan Bongino Show

The Dan Bongino Show

He’s a former Secret Service Agent, former NYPD officer, and New York Times best-selling author. Join Dan Bongino each weekday as he tackles the hottest political issues, debunking both liberal and Republican establishment rhetoric.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2024 iHeartMedia, Inc.